entinostat has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies
Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Entinostat at the selected dose levels in combination with a standard dose of enzalutamide showed a promising safety profile in this small phase I study BACKGROUND: Entinostat inhibits prostate cancer (PCa) growth and suppresses Treg cell function in vitro and in vivo." | 3.01 | Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer. ( Burgess, B; Elkon, J; Lin, J; Ma, Y; Noonepalle, S; Palmer, E; Ricart, B; Siegel, R; Villagra, A; Zevallos-Delgado, C, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, J | 1 |
| Elkon, J | 1 |
| Ricart, B | 1 |
| Palmer, E | 1 |
| Zevallos-Delgado, C | 1 |
| Noonepalle, S | 1 |
| Burgess, B | 1 |
| Siegel, R | 1 |
| Ma, Y | 1 |
| Villagra, A | 1 |
1 trial available for entinostat and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer.
Topics: Benzamides; Humans; Leukocytes, Mononuclear; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasm | 2021 |